SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-20-040436
Filing Date
2020-08-17
Accepted
2020-08-17 16:14:07
Documents
12
Period of Report
2020-08-17

Document Format Files

Seq Description Document Type Size
1 6-K lmnl-6k_20200814.htm 6-K 24381
2 EX-99.1 lmnl-ex991_9.htm EX-99.1 407549
3 EX-99.2 lmnl-ex992_8.htm EX-99.2 485356
4 GRAPHIC gz45gwziccsg000002.jpg GRAPHIC 15701
5 GRAPHIC gz45gwziccsg000007.jpg GRAPHIC 118798
6 GRAPHIC gz45gwziccsg000004.jpg GRAPHIC 23512
7 GRAPHIC gz45gwziccsg000009.jpg GRAPHIC 7909
8 GRAPHIC gz45gwziccsg000001.jpg GRAPHIC 15932
9 GRAPHIC gz45gwziccsg000006.jpg GRAPHIC 8065
10 GRAPHIC gz45gwziccsg000003.jpg GRAPHIC 11169
11 GRAPHIC gz45gwziccsg000005.jpg GRAPHIC 41653
12 GRAPHIC gz45gwziccsg000008.jpg GRAPHIC 23560
  Complete submission text file 0001564590-20-040436.txt   1286475
Mailing Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4
Business Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4 514-341-2115
Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39131 | Film No.: 201110254
SIC: 2834 Pharmaceutical Preparations